rs562364178
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP2
The NM_000388.4(CASR):c.2236G>A(p.Ala746Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A746V) has been classified as Likely benign.
Frequency
Consequence
NM_000388.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant hypocalcemia 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, ClinGen, Labcorp Genetics (formerly Invitae)
- familial hypocalciuric hypercalcemia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Illumina, Orphanet, Genomics England PanelApp
- neonatal severe primary hyperparathyroidismInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
- autosomal dominant hypocalcemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, idiopathic generalized, susceptibility to, 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CASR | ENST00000639785.2 | c.2236G>A | p.Ala746Thr | missense_variant | Exon 7 of 7 | 1 | NM_000388.4 | ENSP00000491584.2 | ||
| CASR | ENST00000498619.4 | c.2266G>A | p.Ala756Thr | missense_variant | Exon 7 of 7 | 1 | ENSP00000420194.1 | |||
| CASR | ENST00000638421.1 | c.2236G>A | p.Ala746Thr | missense_variant | Exon 7 of 7 | 5 | ENSP00000492190.1 | |||
| CASR | ENST00000490131.7 | c.2005G>A | p.Ala669Thr | missense_variant | Exon 5 of 5 | 5 | ENSP00000418685.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152118Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250354 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461620Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727120 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74424 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Nephrolithiasis/nephrocalcinosis Uncertain:1
The p.A746T variant (also known as c.2236G>A), located in coding exon 6 of the CASR gene, results from a G to A substitution at nucleotide position 2236. The alanine at codon 746 is replaced by threonine, an amino acid with similar properties. An alternate amino acid substitution at this codon, p.A746V, was described in a familial hypercalciuric hypercalcemia cohort; however, clinical details were limited (Vargas-Poussou R et al. J. Clin. Endocrinol. Metab., 2016 05;101:2185-95). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Autosomal dominant hypocalcemia 1;C1809471:Familial hypocalciuric hypercalcemia Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 746 of the CASR protein (p.Ala746Thr). This variant is present in population databases (rs562364178, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CASR-related conditions. ClinVar contains an entry for this variant (Variation ID: 410321). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at